Time to Follow the Evidence: Glycemic Control and Cardiovascular Benefits of New Diabetes Medications.
Draznin B, Hirsch IB. Time to Follow the Evidence: Glycemic Control and Cardiovascular Benefits of New Diabetes Medications. Am J Med. 2021 04; 134(4):420-422.